Related Experiment Video

Updated: Jun 14, 2026

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia
09:46

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Published on: February 16, 2024

Treatments for pediatric achalasia: Heller myotomy or pneumatic dilatation?

C Jung1, L Michaud, J-F Mougenot

  • 1Service de gastroentérologie et nutrition pédiatrique, hôpital Robert-Debré, AP-HP, 48, boulevard Sérurier, 75019 Paris, France.

Gastroenterologie Clinique Et Biologique
|March 23, 2010
PubMed

Insights

Pneumatic dilatation shows promise as a primary treatment for achalasia in children over six years old. Both pneumatic dilatation and Heller myotomy can be used as complementary treatments for achalasia in children.

Area of Science:

  • Pediatric Gastroenterology
  • Surgical Innovation
  • Esophageal Motility Disorders

Background:

  • Achalasia treatment involves reducing distal esophageal obstruction.
  • Heller myotomy surgery and pneumatic dilatation are primary treatment options.
  • Evaluating these treatments in pediatric populations is crucial.

Purpose of the Study:

  • To assess the short- and middle-term outcomes of Heller myotomy and pneumatic dilatation in children with achalasia.
  • To compare the efficacy of these treatments based on patient age.

Main Methods:

  • Children under six received Heller myotomy.
  • Children over six were randomized to Heller myotomy or pneumatic dilatation.
  • Outcomes were evaluated at six and 24 months post-procedure.

Main Results:

  • In children under six, 75% and 83% were symptom-free at 6 and 24 months, respectively.
  • In children over six, pneumatic dilatation achieved higher remission rates (55.5% at 6 months, 65% at 24 months) compared to Heller myotomy (44.5% at 6 months, 40% at 24 months).
  • Both treatments demonstrated significant failure rates.

Conclusions:

  • Pneumatic dilatation may be a preferred primary treatment for achalasia in children over six years old.
  • Heller myotomy and pneumatic dilatation can serve as effective complementary therapies.
  • Further research into optimizing achalasia management in pediatric patients is warranted.
Abstract

More Related Videos

Robotic Myotomy and Partial Fundoplication for Achalasia11:19

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Related Concept Videos

Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.